Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FP6ZR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,945
Award facts
- Contract value 100% obligated
- $4,944.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,944.93 by the Defense Logistics Agency on July 29, 2025, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, demonstrating the company's competitive positioning within federal procurement markets despite its woman-owned small business status.
This delivery order is issued under DMS Pharmaceutical Group's significant $500 million single-award IDC with the Defense Logistics Agency under the SPE2DB program, valid through November 2026. The parent contract enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs of military health facilities. Entyvio, a biologic medication used in gastroenterological treatments, represents one component of the extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables that DMS Pharmaceutical Group supplies to Department of Defense healthcare sites nationwide. The contractor's performance of this delivery order will take place at its Park Ridge, Illinois facility.
Quick answers
Who was awarded contract SPE2DB25FP6ZR?
SPE2DB25FP6ZR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FP6ZR worth?
The government has obligated $4,945 on SPE2DB25FP6ZR.
Is contract SPE2DB25FP6ZR an order under another contract?
Yes. SPE2DB25FP6ZR is a delivery order under SPE2DB22D9311, an indefinite delivery contract.
Was contract SPE2DB25FP6ZR competed?
The extent of competition for SPE2DB25FP6ZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award